New Announcement: Metastatic Trial Search is Mobile-Friendly!
Metastatic Trial Search has a new look and is easier to use on all devices. Get started to find a trial that’s right for you.
Biomarkers to Guide MBC Treatment Decisions: dMMR/MSI-H, TMB, and NTRK Fusion
In part 2 of a 3-part series, read about the new recommendations and the dMMR/MSI-H, TMB, and NTRK fusion biomarkers.
The Latest Research on CDK 4/6 Inhibitors
Learn about new CDK 4/6 inhibitor research in different breast cancer subtypes, including HER2+ and triple-negative MBC.
Patient-Reported Outcomes: Including the Patient Voice in MBC Research
Patient-reported outcomes are essential to understand and improve the quality of life of people with MBC. Read more here.
Clinical Trial Outcomes: What is Being Studied and How is it Measured?
Read about outcomes and endpoints and why they are important in determining a trial’s success.
Which Foods, Supplements, and Drugs Should I Avoid During MBC Treatment?
Do your foods, supplements, or drugs interact with your MBC treatment? Click to learn more.
Why You Should Consider Repeat Biopsies
Learn about the importance of repeat biopsies and how they affect treatment decisions and clinical trial eligibility.
Biomarkers to Guide MBC Treatment Decisions: PIK3CA, BRCA1/BRCA2, and PD-L1/PD-1
In this part 1 of a 3-part series, read about new recommendations for using biomarkers to make MBC treatment decisions.
Oncolytic Viruses: Using Viruses to Kill Cancer Cells
Learn how oncolytic viruses work and how to find MBC clinical trials studying this new type of treatment.
Lobular Breast Cancer Metastasis: Highlighting the Researchers
Last in our series, hear from researchers on the latest metastatic lobular breast cancer research.